Cite
HARVARD Citation
Fukutake, K. et al. (2019). Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B. Haemophilia. 25 (4), pp. e247-e256. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fukutake, K. et al. (2019). Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B. Haemophilia. 25 (4), pp. e247-e256. [Online].